filmov
tv
Yervoy
0:11:42
ASCO Lung Cancer Roundtable - NSCLC Trial Updates: Checkmate 227 Opdivo Yervoy Combination Today
0:01:15
Dr. Postow on Nivolumab Combined With Ipilimumab in Melanoma
0:02:35
Dr. Atkins on Long-Term Survival Benefit of Nivolumab/Ipilimumab in Advanced Melanoma
0:04:50
Ipilimumab/Nivolumab in First-Line mRCC
0:01:00
2 Drugs Making Strides in Oncology: Yervoy & Lenvima #Monthlylapinhealth Newsletter reel
0:02:08
Nivolumab with ipilimumab for mRCC
0:00:43
Dr. Eng on the FDA Approval of Nivolumab Plus Ipilimumab in CRC
0:00:39
Dr. Atkinson on When to Use Nivolumab Monotherapy Versus Nivolumab/Ipilimumab Combination
0:03:47
Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer
0:02:00
Dr. Overman on Nivolumab and Ipilimumab in Patients With MSI-H CRC
0:01:22
Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma
0:06:01
Metastatic RCC: Using Frontline Ipilimumab/Nivolumab
0:03:16
Optimizing the Use of Ipilimumab/Nivolumab in mRCC
0:01:27
Dr. Chiang Discusses Ipilimumab Plus Nivolumab in Small Cell Lung Cancer
0:06:12
Nivolumab vs ipilimumab for high risk melanoma patients
0:02:01
Dr. Reardon on Nivolumab/Ipilimumab in Glioblastoma
0:04:59
Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with res...
0:01:25
Dr. Ott Discusses Ipilimumab and Nivolumab in Melanoma
0:01:26
Dr. Andre on Nivolumab Plus Ipilimumab in dMMR/MSI-H mCRC
0:01:00
PRIME-HCC: ipilimumab and nivolumab in liver cancer
0:01:53
İpilimumab İmmunoterapi Prof Dr Başak Oyan Uluç
0:01:49
COSMIC-313: cabozantinib with nivolumab and ipilimumab in untreated aRCC
0:01:16
Opdivo + Yervoy Commercial (2024-2025)
0:02:48
CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma
Назад
Вперёд